biomedcentral.com/bmcmed/article
Bottom,Top,Right1
  • Log on
  •   BioMed Central
  • Journals
  • Gateways
BMC Medicine
official impact factor 6.04
Search for
Advanced search
  • Home
  • Articles
  • Authors
  • Reviewers
  • About this journal
  • My BMC Medicine

Submit a manuscript Register Sign up for article alerts Contact us Follow us on Twitter

Explore BMC Medicine

  •  Editorial Board
  •  Instructions for authors
  •  FAQ
Advertisement

Articles

  • All articles
  • Most popular RSS
  • Archive
  • Article collections

Volume 6 (2008) - December 2008

next >
up
< previous

Research article   Open Access

Upregulation of CRABP1 in human neuroblastoma cells overproducing the Alzheimer-typical Aβ42 reduces their differentiation potential

Markus Uhrig, Peter Brechlin, Olaf Jahn, Yuri Knyazev, Annette Weninger, Laura Busia, Kamran Honarnejad, Markus Otto, Tobias Hartmann BMC Medicine 2008, 6:38 (16 December 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Increased expression of cellular retinoic acid binding protein 1 (CRABP1) in response to beta-amyloid peptide over-expression induces cell proliferation and reduced differentiation potential in human neuroblastoma cells, suggesting a potential mechanism for neurogenesis in Alzheimer's disease.

Research article   Open Access

A controlled trial of the effectiveness of internet continuing medical education

Linda Casebeer, Sally Engler, Nancy Bennett, Martin Irvine, Destry Sulkes, Marc DesLauriers, Sijian Zhang BMC Medicine 2008, 6:37 (4 December 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Doctors are more likely to make evidence-based clinical choices after taking part in selected internet continuing medical education (CME) activities, suggesting that such internet-based education may be a credible, high-impact source of CME.


  • Terms and Conditions
  • Privacy statement
  • Press
  • Information for advertisers
  • Jobs at BMC
  • Support
  • Contact us

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.